Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soft Tissue and Uterine Leiomyosarcoma
Suzanne George, César Serrano, Martee L. Hensley, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 2, pp. 144-150
Open Access | Times Cited: 197

Showing 1-25 of 197 citing articles:

Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine
Adriana C. Gamboa, Alessandro Gronchi, Kenneth Cardona
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 3, pp. 200-229
Open Access | Times Cited: 419
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 8, pp. 1044-1054
Closed Access | Times Cited: 80
Incidence and survival of European adolescents and young adults diagnosed with sarcomas: EUROCARE-6 results
Annalisa Trama, Paolo Lasalvia, Dan Stark, et al.
European Journal of Cancer (2025) Vol. 217, pp. 115212-115212
Open Access | Times Cited: 2
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Lorenzo D’Ambrosio, Nathan Touati, Jean‐Yves Blay, et al.
Cancer (2020) Vol. 126, Iss. 11, pp. 2637-2647
Open Access | Times Cited: 118
ALT Positivity in Human Cancers: Prevalence and Clinical Insights
Danny MacKenzie, Andrea Watters, Julie T. To, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2384-2384
Open Access | Times Cited: 62
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Amir Momeni Boroujeni, Elham Yousefi, Ridin Balakrishnan, et al.
Modern Pathology (2023) Vol. 36, Iss. 4, pp. 100084-100084
Closed Access | Times Cited: 24
Therapeutic advances in leiomyosarcoma
Kristine Peregrino Lacuna, Sminu Bose, Matthew Ingham, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 24
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile
Annalisa Astolfi, Margherita Nannini, Valentina Indio, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2126-2126
Open Access | Times Cited: 67
Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
Eve Merry, Khin Thway, Robin L. Jones, et al.
npj Precision Oncology (2021) Vol. 5, Iss. 1
Open Access | Times Cited: 42
The proteomic landscape of soft tissue sarcomas
Jessica Burns, Christopher P. Wilding, Lukáš Krásný, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
Amir Momeni Boroujeni, Kerry Mullaney, Sara DiNapoli, et al.
Modern Pathology (2024) Vol. 37, Iss. 5, pp. 100474-100474
Closed Access | Times Cited: 6
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease
Matthew L. Hemming, Kelly S. Klega, Justin Rhoades, et al.
JCO Precision Oncology (2019), Iss. 3, pp. 1-11
Open Access | Times Cited: 52
Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis
Alessandro Rizzo, Margherita Nannini, Annalisa Astolfi, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1899-1899
Open Access | Times Cited: 43
Leiomyosarcoma
Nicolás Devaud, Olga Vornicova, Albiruni R. Abdul Razak, et al.
Surgical Oncology Clinics of North America (2022) Vol. 31, Iss. 3, pp. 527-546
Closed Access | Times Cited: 25
Aberrant Activation of Cell-Cycle–Related Kinases and the Potential Therapeutic Impact of PLK1 or CHEK1 Inhibition in Uterine Leiomyosarcoma
Kosuke Yoshida, Akira Yokoi, Tomofumi Yamamoto, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2147-2159
Open Access | Times Cited: 22
Uterine Leiomyosarcoma
Katherine Byar, Tricia Fredericks
Journal of the Advanced Practitioner in Oncology (2022) Vol. 13, Iss. 1, pp. 70-76
Open Access | Times Cited: 19
Hereditary Gynecologic Cancer Syndromes – A Narrative Review
Stoyan Kostov, Rafał Watrowski, Yavor Kornovski, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 381-405
Open Access | Times Cited: 19
Primary Leiomyosarcoma of the Kidney: A Case Report
Srijana Khati, Sagar Rana Magar, Ankita Simkhada, et al.
Clinical Case Reports (2025) Vol. 13, Iss. 1
Open Access
Validation of biomarkers and clinical scores for the detection of uterine leiomyosarcoma: a case-control study with an update of pLMS
Marcus Vollmer, Günter Köhler, Julia Caroline Radosa, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
A decade of Insight: Understanding Primary Leiomyosarcoma of the Bone.
Himanshu Rohela, Anila Sharma, Vaibhav Sahu, et al.
Journal of Orthopaedic Reports (2025), pp. 100556-100556
Open Access
Doxorubicin and trabectedin in leiomyosarcoma: pioneering a new era of smart combinations in soft tissue sarcomas
Tarek Assi, Axel Le Cesne
Future Oncology (2025), pp. 1-4
Closed Access
Diagnostic challenges of retroperitoneal leiomyosarcoma: A case of confusion with adrenal tumour
Víctor Pedrero, Víctor Cristóbal Redondo, Antonio Tejera-Muñoz, et al.
Revista Española de Patología (2025) Vol. 58, Iss. 2, pp. 100807-100807
Closed Access
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score‐Matched Analysis
Luc M. Berclaz, Vindi Jurinović, Anton Burkhard‐Meier, et al.
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
Analysis of demographics and treatment outcomes for gastrointestinal leiomyosarcoma based on the SEER database
Yanan Bao, Xudong Yang, Quanming Zhao, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top